From: Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports
Previous Negative Biopsy Cohort
ERSPC R4 (+)
ERSPC R4 (−)
Total
SelectMDx test (+)
5
15
20
SelectMDx test (−)
0
14
29
34